17.58
Immunome Inc (IMNM) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | 4.015 |
| Operating Expenses |
31.69%
78.14
|
59.33 | 72.86 | 60.14 | 50.49 |
| Operating Income/Loss |
31.69%
-78.14
|
-59.33 | -72.86 | -60.14 | -46.48 |
| Net Interest Income/Expense |
8.81%
5.008
|
5.492 | 2.961 | 2.681 | 3.081 |
|
|
35.83%
-73.13
|
-53.84 | -69.90 | -57.46 | -43.40 |
| Basic Average Shares |
0.12%
113.27
|
113.14 | 2.5267 | 87.96 | 87.01 |
| Diluted Average Shares |
0.12%
113.27
|
113.14 | 2.5267 | 87.96 | 87.01 |
| Basic Earnings Per Share |
35.42%
-0.65
|
-0.48 | -0.75 | -0.65 | -0.50 |
| Diluted Earnings Per Share |
35.42%
-0.65
|
-0.48 | -0.75 | -0.65 | -0.50 |
자본화:
|
볼륨(24시간):